| Deal Structure and Party Summary | ||
|---|---|---|
| Deal Structure | Stock or Equity Purchase | |
| Acquirer | GoodRx Holdings, Inc. | |
| Public | Yes | |
| Industry | Business Services | |
| Private equity sponsorship | No | |
| Seller | TherapeuticsMD, Inc. | |
| Public | Yes | |
| Industry | Healthcare | |
| Private equity sponsorship | No | |
| Target | vitaCare Prescription Services, Inc. | |
| Public | No | |
| Industry | Healthcare | |
| Private equity sponsorship(s) | No | |
| Key Transaction Characteristics and Terms | ||
|---|---|---|
| Status | Pending | |
| Announcement date | March 7, 2022 | |
| Transaction value | $150 million | |
| Form of consideration | Cash | |
| Go-Shop/No-Shop Terms | ||
|---|---|---|
| No-Shop Provision | Redacted | |
| Indemnification | ||
|---|---|---|
| Indemnity Cap | ||
| Dollar amount of cap | Redacted | |
| Indemnification deductible or basket | ||
| Basket | Redacted | |
| Deductible | Redacted | |
| Transaction Advisors | ||
|---|---|---|
| Seller / Target Counsel | ||
| Law firm #1 | DLA Piper | |
| Individual attorney(s) | Joshua Samek | |
| Acquirer Counsel | ||
| Law firm #1 | M&H, LLP | |
| Individual attorney(s) | Kerry T. Smith | |
| Seller / Target Financial Advisors | ||
| Financial advisor #1 | Locust Walk | |